Cite
APA Citation
Blevins, T. C., & Farooki, A. (2017). bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus. Postgraduate medicine, 129(1), 159–168. http://access.bl.uk/ark:/81055/vdc_100040136331.0x00005f